8857 related articles for article (PubMed ID: 22943872)
1. [Paraneoplastic retinopathy].
Liu Y; Lei B
Zhonghua Yan Ke Za Zhi; 2012 Jul; 48(7):653-6. PubMed ID: 22943872
[TBL] [Abstract][Full Text] [Related]
2. Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction.
Kondo M; Sanuki R; Ueno S; Nishizawa Y; Hashimoto N; Ohguro H; Yamamoto S; Machida S; Terasaki H; Adamus G; Furukawa T
PLoS One; 2011; 6(5):e19911. PubMed ID: 21611200
[TBL] [Abstract][Full Text] [Related]
3. [Paraneoplastic retinopathy and optic neuropathy].
Ikawa M; Kuriyama M
Brain Nerve; 2010 Apr; 62(4):371-6. PubMed ID: 20420177
[TBL] [Abstract][Full Text] [Related]
4. Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression.
Karatsai E; Robson AG; Taylor SRJ
JAMA Ophthalmol; 2019 May; 137(5):564-567. PubMed ID: 30896772
[TBL] [Abstract][Full Text] [Related]
5. Melanoma-associated paraneoplastic retinopathy: case report and review of the literature.
Boeck K; Hofmann S; Klopfer M; Ian U; Schmidt T; Engst R; Thirkill CE; Ring J
Br J Dermatol; 1997 Sep; 137(3):457-60. PubMed ID: 9349350
[TBL] [Abstract][Full Text] [Related]
6. [Paraneoplastic retinopathy associated with cutaneous melanoma. An update apropos of a case].
Rougier MB; Hostyn P; Bret-Dibat C; Delaunay MM; Riss I; Le Rebeller MJ
J Fr Ophtalmol; 1995; 18(5):396-403. PubMed ID: 7560778
[TBL] [Abstract][Full Text] [Related]
7. [Case report of melanoma-associated retinopathy associated with positive auto-antibodies against retinal bipolar cells].
Hanaya J; Nakamura Y; Nejima R; Miyata K; Mera K; Ohguro H; Yamamoto S
Nippon Ganka Gakkai Zasshi; 2011 Jun; 115(6):541-6. PubMed ID: 21735759
[TBL] [Abstract][Full Text] [Related]
8. [Cancer associated retinopathy (CAR). Two clinical cases and review of the literature].
Matus G; Dicato M; Focan C
Rev Med Liege; 2007 Mar; 62(3):166-9. PubMed ID: 17511385
[TBL] [Abstract][Full Text] [Related]
9. [Cancer-associated retinopathy].
Ohguro H; Takaya T; Ogawa K; Suzuki J; Nakagawa T
Nippon Ganka Gakkai Zasshi; 1997 Apr; 101(4):283-7. PubMed ID: 9136565
[TBL] [Abstract][Full Text] [Related]
10. Corticosteroid treatment for melanoma-associated retinopathy: effect on visual acuity and electrophysiologic findings.
Jacobzone C; Cochard-Marianowski C; Kupfer I; Bettembourg S; Dordain Y; Misery L; Cochener B; Sassolas B
Arch Dermatol; 2004 Oct; 140(10):1258-61. PubMed ID: 15492190
[TBL] [Abstract][Full Text] [Related]
11. Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo.
Lei B; Bush RA; Milam AH; Sieving PA
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):262-6. PubMed ID: 10634629
[TBL] [Abstract][Full Text] [Related]
12. Serum TRPM1 autoantibodies from melanoma associated retinopathy patients enter retinal on-bipolar cells and attenuate the electroretinogram in mice.
Xiong WH; Duvoisin RM; Adamus G; Jeffrey BG; Gellman C; Morgans CW
PLoS One; 2013; 8(8):e69506. PubMed ID: 23936334
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.
Adamus G; Ren G; Weleber RG
BMC Ophthalmol; 2004 Jun; 4():5. PubMed ID: 15180904
[TBL] [Abstract][Full Text] [Related]
14. Melanoma-associated retinopathy with anti-TRPM1 autoantibodies showing concomitant Off-bipolar cell dysfunction.
Hung WC; Cheng HC; Wang AG
Doc Ophthalmol; 2022 Dec; 145(3):263-270. PubMed ID: 36173494
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies in melanoma-associated retinopathy target TRPM1 cation channels of retinal ON bipolar cells.
Dhingra A; Fina ME; Neinstein A; Ramsey DJ; Xu Y; Fishman GA; Alexander KR; Qian H; Peachey NS; Gregg RG; Vardi N
J Neurosci; 2011 Mar; 31(11):3962-7. PubMed ID: 21411639
[TBL] [Abstract][Full Text] [Related]
16. [Melanoma-associated retinopathy. Apropos of a case and review of the literature].
Bret-Dibat C; Rougier MB; Le Rebeller MJ; Delaunay M
Bull Cancer; 1996 Dec; 83(12):1019-22. PubMed ID: 9116366
[TBL] [Abstract][Full Text] [Related]
17. Cancer-retina antigens as potential paraneoplastic antigens in melanoma-associated retinopathy.
Bazhin AV; Dalke C; Willner N; Abschütz O; Wildberger HG; Philippov PP; Dummer R; Graw J; de Angelis MH; Schadendorf D; Umansky V; Eichmüller SB
Int J Cancer; 2009 Jan; 124(1):140-9. PubMed ID: 18814277
[TBL] [Abstract][Full Text] [Related]
18. [Ocular manifestations of cancer].
De Potter P; Disneur D; Levecq L; Snyers B
J Fr Ophtalmol; 2002 Feb; 25(2):194-202. PubMed ID: 11941243
[TBL] [Abstract][Full Text] [Related]
19. [Ocular paraneoplastic syndrome: cancer-associated retinopathy].
Sampedro A; Carballo C; Barbón JJ; Andrés A; Viña C; Abelairas V
Arch Soc Esp Oftalmol; 2013 Oct; 88(10):407-9. PubMed ID: 24060306
[TBL] [Abstract][Full Text] [Related]
20. CLINICAL COURSE OF PARANEOPLASTIC RETINOPATHY WITH ANTI-TRPM1 AUTOANTIBODY IN JAPANESE COHORT.
Ueno S; Inooka D; Nakanishi A; Okado S; Yasuda S; Kominami T; Sayo A; Morimoto T; Kondo M; Katagiri S; Hayashi T; Terasaki H
Retina; 2019 Dec; 39(12):2410-2418. PubMed ID: 30260920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]